HealthEquity, Inc. (NASDAQ:HQY) Receives $110.71 Average Price Target from Analysts

HealthEquity, Inc. (NASDAQ:HQY) has been given an average rating of “Moderate Buy” by the fourteen brokerages that are currently covering the stock, Marketbeat.com reports. One investment analyst has rated the stock with a hold recommendation and thirteen have assigned a buy recommendation to the company. The average 1 year target price among brokers that have issued ratings on the stock in the last year is $110.71.

HQY has been the subject of a number of research analyst reports. Barrington Research lifted their target price on HealthEquity from $105.00 to $120.00 and gave the stock an “outperform” rating in a report on Monday, December 2nd. JMP Securities lifted their price objective on HealthEquity from $105.00 to $107.00 and gave the stock a “market outperform” rating in a report on Tuesday, December 10th. Bank of America upped their target price on shares of HealthEquity from $100.00 to $120.00 and gave the company a “buy” rating in a research note on Wednesday, November 13th. Mizuho started coverage on shares of HealthEquity in a report on Wednesday, December 4th. They set an “outperform” rating and a $126.00 price target on the stock. Finally, The Goldman Sachs Group started coverage on shares of HealthEquity in a report on Friday, November 15th. They set a “neutral” rating and a $108.00 price objective for the company.

HealthEquity Stock Performance

Shares of HQY opened at $98.69 on Friday. The company has a quick ratio of 4.10, a current ratio of 3.20 and a debt-to-equity ratio of 0.51. The stock has a market cap of $8.55 billion, a P/E ratio of 90.54, a P/E/G ratio of 1.08 and a beta of 0.54. The business’s 50 day moving average price is $97.30 and its 200-day moving average price is $85.69. HealthEquity has a 52 week low of $65.01 and a 52 week high of $105.82.

Insider Buying and Selling at HealthEquity

In other news, Director Frank Corvino sold 1,039 shares of the stock in a transaction that occurred on Wednesday, November 6th. The stock was sold at an average price of $96.10, for a total value of $99,847.90. Following the sale, the director now directly owns 3,784 shares in the company, valued at approximately $363,642.40. This represents a 21.54 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Stuart B. Parker sold 25,000 shares of the business’s stock in a transaction on Thursday, December 12th. The shares were sold at an average price of $96.72, for a total value of $2,418,000.00. Following the transaction, the director now owns 19,061 shares of the company’s stock, valued at approximately $1,843,579.92. The trade was a 56.74 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 34,289 shares of company stock worth $3,355,718 over the last ninety days. Company insiders own 2.20% of the company’s stock.

Institutional Trading of HealthEquity

Large investors have recently modified their holdings of the company. Holocene Advisors LP purchased a new position in HealthEquity during the 3rd quarter valued at about $1,246,000. GSA Capital Partners LLP purchased a new position in HealthEquity during the third quarter valued at approximately $638,000. Natixis Advisors LLC increased its holdings in HealthEquity by 29.8% during the third quarter. Natixis Advisors LLC now owns 209,175 shares of the company’s stock valued at $17,122,000 after buying an additional 48,009 shares during the period. Vaughan Nelson Investment Management L.P. raised its stake in HealthEquity by 36.7% in the third quarter. Vaughan Nelson Investment Management L.P. now owns 843,423 shares of the company’s stock worth $69,034,000 after buying an additional 226,563 shares in the last quarter. Finally, Oppenheimer Asset Management Inc. lifted its holdings in HealthEquity by 29.4% during the second quarter. Oppenheimer Asset Management Inc. now owns 64,214 shares of the company’s stock worth $5,535,000 after buying an additional 14,573 shares during the period. Hedge funds and other institutional investors own 99.55% of the company’s stock.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.